|
MACF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.32969240857528E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0193846594907E-12 |
| Normal-vs-Stage2 |
7.767700E-02 |
| Normal-vs-Stage3 |
5.09690001315732E-09 |
| Normal-vs-Stage4 |
1.34800000051172E-07 |
| Stage1-vs-Stage2 |
1.878420E-02 |
| Stage1-vs-Stage3 |
9.553600E-01 |
| Stage1-vs-Stage4 |
9.291000E-01 |
| Stage2-vs-Stage3 |
3.380000E-02 |
| Stage2-vs-Stage4 |
4.932500E-02 |
| Stage3-vs-Stage4 |
9.078400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47613041182149E-12 |
| Normal-vs-AfricanAmerican |
6.01129999999728E-05 |
| Normal-vs-Asian |
5.9904999849536E-09 |
| Caucasian-vs-AfricanAmerican |
3.397000E-01 |
| Caucasian-vs-Asian |
2.576000E-01 |
| AfricanAmerican-vs-Asian |
7.960600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.73309996856597E-09 |
| Normal-vs-Female |
3.10995673657999E-12 |
| Male-vs-Female |
8.746400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.50119916497715E-11 |
| Normal-vs-Age(41-60Yrs) |
1.28129729048965E-11 |
| Normal-vs-Age(61-80Yrs) |
1.842260E-03 |
| Normal-vs-Age(81-100Yrs) |
2.801600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.531200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.165680E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.998000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.664160E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.568400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.254600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.180000E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
7.662300E-02 |
| Classical-VS-Normal |
1.11022302462516E-16 |
| Tall-VS-Follicular |
1.62209999876595E-08 |
| Tall-VS-Other |
4.267900E-02 |
| Tall-VS-Normal |
2.82050049982274E-10 |
| Follicular-VS-Other |
3.249800E-01 |
| Follicular-VS-Normal |
7.318200E-01 |
| Other-VS-Normal |
3.635000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.70169999999825E-06 |
| Normal-vs-N1 |
4.57289999977739E-07 |
| N0-vs-N1 |
8.476200E-02 |
|
|
